Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04290455 · ClinicalTrials.gov registry record · NA
Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure
A NA study, sponsored by University of California, Los Angeles.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT04290455 is a NA study that was terminated before completion, run by University of California, Los Angeles. The registered enrollment target is 2 participants.
The verdict
NCT04290455, a NA study, was terminated before completion, sponsored by University of California, Los Angeles.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Objective: To investigate the efficacy of microblepharoexfoliation by BlephEx™ as an adjunct to eyelid cleansing in the treatment of anterior blepharitis and to validate the grading score of lid contamination to describe the severity of anterior blepharitis. Design: A prospective, randomized, paired-eye trial. Methods: One of patients' eyes will be randomized into the microblepharoexfoliation group which will use the BlephExTM device during the in-house lid cleansing procedure. The other eye will be in the control group which will receive conventional lid cleansing. The parameters indicating the efficacy of the microblepharoexfoliation procedure including the symptom scoring system; the Standard Patient Evaluation of Eye Dryness Questionnaire (SPEED), lashes contamination, lid margin redness, number of preservative free artificial tears used per day, meibomian gland quality and expressibility will be recorded at the screening visit and 3-week follow-up visit. The patient will be instructed to do warm compression and lid cleansing at home once a day with Optase eyelid scrubs for 3 weeks on both eyes before follow-up.
Interventions
- DEVICE Microblepharoexfoliative procedure with BlephEx™
- PROCEDURE Eyelid cleansing with eyelid wipes (Optase)
- PROCEDURE Daily eyelid cleansing with eyelid wipes (Optase)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2020-06-02 |
| Est. Completion | 2020-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04290455
The ClinicalTrials.gov registry entry for NCT04290455 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Microblepharoexfoliative procedure with BlephEx™ is the first listed.
NCT04290455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04290455 about?
NCT04290455 is a clinical study titled "Treatment of Anterior Blepharitis With Microblepharoexfoliation Procedure". Objective: To investigate the efficacy of microblepharoexfoliation by BlephEx™ as an adjunct to eyelid cleansing in the treatment of anterior blepharitis and to validate the grading score of lid contamination to describe the severity of anterior blepharitis. Design: A prospective, randomized, paired...
What is the current status of trial NCT04290455?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2020-06-02. Estimated completion is 2020-11-01.
What interventions are being tested in trial NCT04290455?
The interventions under investigation include: Microblepharoexfoliative procedure with BlephEx™ (DEVICE), Eyelid cleansing with eyelid wipes (Optase) (PROCEDURE), Daily eyelid cleansing with eyelid wipes (Optase) (PROCEDURE).
Who is sponsoring clinical trial NCT04290455?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.